
Neumic Therapeutics Ltd
New Zealand · Biotech & life sciences · Undetermined

Legit.Health
Spain · HealthTech · Seed
Compatibility /100
43/100
Medium potentialWhy talk
- Complementary sectors: Biotech & life sciences × HealthTech — room for a joint offer or co-selling.
- Stage not comparable (Undetermined / Seed).
- Legit.Health has strong traction in a related sector (HealthTech): CE-marked medical device (ISO 13485), with partners listed such as NHS, SERMAS, SESPA, Sanitas, Adeslas, Novartis and Almirall — a proven go-to-market and customer relationships Neumic Therapeutics Ltd can learn from or tap.
Score anatomy
Each segment is what one dimension adds, out of 100.
Score by goal
Dimension by dimension
Needs ↔ offers
3.5 / 10 pts
Legit.Health can help Neumic Therapeutics Ltd.
- Neumic Therapeutics Ltd likely needs first paying customers — Legit.Health (Spain, Seed, $5.7M raised, strong traction) can offer access to its customer base (inferred from public profile).
Market bridge
2.5 / 10 pts
Distant markets.
- Legit.Health is based in Spain (Europe): a landing pad on another continent, both ways.
Customer potential
4.3 / 5 pts
Strong customer or channel potential.
- Legit.Health has strong traction in a related sector (HealthTech): CE-marked medical device (ISO 13485), with partners listed such as NHS, SERMAS, SESPA, Sanitas, Adeslas, Novartis and Almirall — a proven go-to-market and customer relationships Neumic Therapeutics Ltd can learn from or tap.
Sector synergy
25.0 / 50 pts
Complementary sectors.
- Complementary sectors: Biotech & life sciences × HealthTech — room for a joint offer or co-selling.
Stage complementarity
7.5 / 25 pts
Weak stage signal.
- Stage not comparable (Undetermined / Seed).
How the score works
Each dimension gives a value between 0 and 1, multiplied by its weight; the compatibility is the sum (0–100). Weights for “Peers”: Needs ↔ offers 10, Market bridge 10, Customer potential 5, Sector synergy 50, Stage complementarity 25. Declared needs and offers count fully; when a startup has declared nothing, a few needs/offers are inferred from its public profile (for example, no known traction ⇒ needs customers) and count at half value.
Potential blends compatibility (65%) with the mean global score of both startups (35%): 46/100 — high from 50, medium from 36.